Sie sind auf Seite 1von 31

PLATELET PRODUCTION

MEGAKARYOPOIESIS THROMBOPOIESIS
marjijamias,rmt

Megakaryocyte Progenitors
CFU - GEMM
TPO, Meg CSF, IL-3

marjijamias,rmt

BFU Meg

CFU Meg

LD CFU - Meg

marjijamias,rmt

Terminal Megakaryocyte Differentiation


Proliferative phase MK-I : megakaryoblast MK-II : promegakaryocyte MK-III : mature megakaryocyte terminal differentiation

Features of the Three Terminal Megakaryocyte Differentiation Stages


marjijamias,rmt

MK-I % precursors Diameter (um) Nucleus Nucleoli Chromatin N:C Mitosis Endomitosis Cytoplasm 20 14-18 Round 2-6 Homogenous 3:1 Absent Present Basophilic

MK-II 25 15-40 Indented Variable Condensed 1:2 Absent Ends Basophilic and Granular

MK-III 55 30-50 Multilobed Not visible Condensed 1:4 Absent Absent Eosinophilic and Granular

-granules
-granules DMS

present
present present***

present
present present

present
present present

marjijamias,rmt

LD-CFU Meg

MK-I

MK-II

MK-III

TPO, IL-1

Proplatelet processes

Platelet shedding

marjijamias,rmt

marjijamias,rmt

Mature Megakaryocyte is confused with :


Normal osteoclast Osteoblast Reticulum cell Abnormal mutlinucleated erythroblast Multinucleated plasma cell Tumor cells Reed-Sternberg cells

marjijamias,rmt

Hormones and Cytokines That Control Megakaryocytopoiesis


TPO IL-3 IL-6 IL-11

Differentiation to progenitors Differentiation to Megakaryocytes Late Maturation Thrombopoiesis Clinical Use

+ + + 0 +

+ + 0 -

0 0 + + -

0 + + + +

marjijamias,rmt

marjijamias,rmt

Proposed mechanisms of platelet release from megakaryocytes


1. Formation of Cell Processes 2. Formation of Demarcation Membrane System

*** 1 megakaryocyte : 1000 5000 platelets (2000-4000)

marjijamias,rmt

marjijamias,rmt

Diameter : 1 to 4 um Thickness : 0.5 1.0 um MCV : 5 to 7 fL

marjijamias,rmt

PARTS

marjijamias,rmt

marjijamias,rmt

1. PLASMA MEMBRANE (Hyalomere)


7.5 nm thickness Trilaminar unit structure Glycocalyx (10 to 50 nm)

marjijamias,rmt

Phospholipid Constituents
Phosphatidylserine Phosphatidylcholine

Phosphatidylinositol ***vWF : for platelet adhesion

marjijamias,rmt

2. Submembrane Area
Separates the organelles within the inner matrix of unaltered platelets from the internal side of the platelet cell wall. Contains organized system of filaments.

marjijamias,rmt

3. PLATELEL CYTOSKELETON (SOL-GEL Zone)


Represents the matrix of the platelet cytoplasm, circumferential microtubule system and randomly arranged microfilaments that form an intraplatelet matrix - - - support the platelet discoid shape. Microfilaments : contain significant amount of THROMBOSTHENIN

marjijamias,rmt

THROMBOSTHENIN : actin and myosin

marjijamias,rmt

Microtubule system plays an important role in the contractile response of platelets to stimulation

marjijamias,rmt

4. ORGANELLES
A. DENSE BODIES : 250 350 nm in diameter 1. ADP (adenosine diphosphate) : most important : binds to specific receptors and initiates platelet aggregation

marjijamias,rmt

2. ATP 3. Calcium : important in the activation of membrane phospholipases 4. Magnesium 5. Serotonin 6. GDP; GTP

marjijamias,rmt

B. ALPHA GRANULES : 300 to 500 nm 1. Platelet specific protein *Platelet factor 4 (PF4) * B Thromboglobulin Family : bind heparin

*gp IIb/IIIa : receptors for fibrinogen and vWF

marjijamias,rmt

2. Multimerin 3. Adhesive glycoproteins Fibrinogen vWF Fibronectin Thrombospondin Vitronectin

marjijamias,rmt

4. Coagulation Factors Factor V Factor XI Protein S 5. Mitogenic Factors Platelet derived growth factor (PDGF) Transforming growth factor B Endothelial Cell Growth Factor Epidermal Growth Factor (EGF)

marjijamias,rmt

6. Fibrinolytic Inhibitors 2-plasmin inhibitor PAI 1

7. Membrane Associated Proteins P-selectin GMP 33 24-KD GTP binding protein GP IV (CD 36) Osteonectin

marjijamias,rmt

C. LYSOSOMES : contain acid hydrolases elastase collagenase cathepsin heparinase enzymes for polysaccharides

marjijamias,rmt

Life Span Turnover Rate

marjijamias,rmt

Normally,
The rate of platelet release from megakaryocytes is equivalent to the rate of platelet removal from the circulation.

Net turnover : 35,000+/-4,300 platelets/mL /day

marjijamias,rmt

2 populations:
YOUNG : hemostatically more effective OLD : hemostatically less effective

marjijamias,rmt

Life Span
7 10 days / 9-11 days

Das könnte Ihnen auch gefallen